{"filing":{"accession_number":"0001185185-26-003211","cik":"0001864531","ticker":"VSEEW","company_name":"VSEE HEALTH, INC.","form":"8-K","filing_date":"2026-07-31","report_date":"2026-06-30","primary_document":"vsee8k073026.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1864531/000118518526003211/vsee8k073026.htm"},"events":[{"id":22440,"run_id":20299,"accession_number":"0001185185-26-003211","anchor_item_number":"1.01","event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.88,"summary":"VSee Health issued an unsecured convertible promissory note for $336,000 principal to Labrys on June 30, 2026, with 12% interest and a maturity date of June 30, 2027. The note includes conversion rights into common stock and standard prepayment/acceleration provisions, creating a direct financial obligation material to the company's capital structure.","company_name":"VSEE HEALTH, INC.","ticker":"VSEEW","filing_date":"2026-07-31","form":"8-K","submitted_at":null,"items":[{"id":22380,"accession_number":"0001185185-26-003211","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement.","event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"VSee Health issued an unsecured convertible promissory note for $336,000 principal to Labrys on June 30, 2026, creating a direct financial obligation due June 30, 2027. While the note is convertible into common stock, the primary event disclosed under Item 1.01 is the creation of a new debt instrument with specified interest (12%), repayment terms, and prepayment/acceleration provisions. This is a debt issuance rather than a dilutive equity issuance, though the convertibility feature is material to the terms.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-01T00:20:01.511399+00:00","company_name":"","ticker":null,"filing_date":""},{"id":22381,"accession_number":"0001185185-26-003211","item_number":"2.03","item_title":"Creation of a Direct Financial Obligation","event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"Item 2.03 discloses creation of a direct financial obligation, with the substance incorporated by reference from Item 1.01. This structure is typical for debt issuances, credit facilities, or material financing arrangements. Without access to Item 1.01 details, the Item 2.03 heading and cross-reference pattern strongly indicate a debt or financing event material to investors.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-01T00:20:01.511399+00:00","company_name":"","ticker":null,"filing_date":""},{"id":22382,"accession_number":"0001185185-26-003211","item_number":"3.02","item_title":"Unregistered Sales of Equity Securities.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"reasoning":"Item 3.02 discloses an unregistered sale of equity securities under Section 4(a)(2) and Regulation D. The filing specifically references \"the Labrys Note, including the shares of common stock issuable upon conversion thereof,\" indicating a convertible debt instrument with dilutive equity conversion rights. This is a classic private placement structure material to investors assessing capital structure and ownership dilution.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-01T00:20:01.511399+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":22380,"accession_number":"0001185185-26-003211","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement.","event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"VSee Health issued an unsecured convertible promissory note for $336,000 principal to Labrys on June 30, 2026, creating a direct financial obligation due June 30, 2027. While the note is convertible into common stock, the primary event disclosed under Item 1.01 is the creation of a new debt instrument with specified interest (12%), repayment terms, and prepayment/acceleration provisions. This is a debt issuance rather than a dilutive equity issuance, though the convertibility feature is material to the terms.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-01T00:20:01.511399+00:00","company_name":"VSEE HEALTH, INC.","ticker":"VSEEW","filing_date":"2026-07-31"},{"id":22381,"accession_number":"0001185185-26-003211","item_number":"2.03","item_title":"Creation of a Direct Financial Obligation","event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"Item 2.03 discloses creation of a direct financial obligation, with the substance incorporated by reference from Item 1.01. This structure is typical for debt issuances, credit facilities, or material financing arrangements. Without access to Item 1.01 details, the Item 2.03 heading and cross-reference pattern strongly indicate a debt or financing event material to investors.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-01T00:20:01.511399+00:00","company_name":"VSEE HEALTH, INC.","ticker":"VSEEW","filing_date":"2026-07-31"},{"id":22382,"accession_number":"0001185185-26-003211","item_number":"3.02","item_title":"Unregistered Sales of Equity Securities.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"reasoning":"Item 3.02 discloses an unregistered sale of equity securities under Section 4(a)(2) and Regulation D. The filing specifically references \"the Labrys Note, including the shares of common stock issuable upon conversion thereof,\" indicating a convertible debt instrument with dilutive equity conversion rights. This is a classic private placement structure material to investors assessing capital structure and ownership dilution.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-01T00:20:01.511399+00:00","company_name":"VSEE HEALTH, INC.","ticker":"VSEEW","filing_date":"2026-07-31"}]}